801-2, Jindong Mansion, No. 536 Xueshi Road, Yinzhou, Ningbo 315100, P.R.China
Home ProductsOral Medications

Diabetes Oral Medications Metformin Hydrochloride Tablets 500 mg 850mg

Diabetes Oral Medications Metformin Hydrochloride Tablets 500 mg 850mg

    • Diabetes Oral Medications Metformin Hydrochloride Tablets 500 mg 850mg
  • Diabetes Oral Medications Metformin Hydrochloride Tablets 500 mg 850mg

    Product Details:

    Place of Origin: China
    Brand Name: Newlystar
    Certification: GMP
    Model Number: 500mg, 850mg

    Payment & Shipping Terms:

    Minimum Order Quantity: One million tablets
    Price: Negotiation
    Packaging Details: 10’s/blister
    Delivery Time: 45days
    Payment Terms: L/C, T/T
    Supply Ability: One million tablets per day
    Contact Now
    Detailed Product Description
    Product: Metformin Hydrochloride Tablets Specification: 500mg, 850mg
    Standard: BP, USP Packing: 10’s/blister
    High Light:

    oral treatment

    ,

    oral preparation

    Diabetes Oral Medications Metformin Hydrochloride Tablets 500 mg 850mg

     

     

    Product : Metformin Hydrochloride Tablets

    Specification : 500mg, 850mg

    Standard : BP, USP

    Packing : 10’s/blister

     

    Description :

    Metformin hydrochloride tablets and metformin hydrochloride Extended-Release Tablets are oral antihyperglycemic drugs used in the management of type 2 diabetes.

     

    Indications and Usage

    Metformin hydrochloride Tablets is indicated as an adjunct to diet and exercise to improve glycemic control in adults and children with type 2 diabetes mellitus.

    Metformin hydrochloride Extended-Release Tablets is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

     

    Pharmacodynamics

    Metformin is an oral antihyperglycemic agent that improves glucose tolerance in patients with NIDDM, lowering both basal and postprandial plasma glucose. Metformin is not chemically or pharmacologically related to any other class of oral antihyperglycemic agents. Unlike sulfonylureas, metformin does not produce hypoglycemia in either patients with NIDDM or healthy subjects and does not cause hyperinsulinemia. Metformin does not affect insulin secretion.

     

    Mechanism of Action

    Metformin is an antihyperglycemic agent which improves glucose tolerance in patients with type 2 diabetes, lowering both basal and postprandial plasma glucose. Its pharmacologic mechanisms of action are different from other classes of oral antihyperglycemic agents. Metformin decreases hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity by increasing peripheral glucose uptake and utilization. Unlike sulfonylureas, metformin does not produce hypoglycemia in either patients with type 2 diabetes or normal subjects (except in special circumstances, see PRECAUTIONS) and does not cause hyperinsulinemia. With metformin therapy, insulin secretion remains unchanged while fasting insulin levels and day-long plasma insulin response may actually decrease.

    Contact Details
    Newlystar (Ningbo) Medtech Co.,Ltd.

    Contact Person: Luke Liu

    Send your inquiry directly to us (0 / 3000)

    Other Products